These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

757 related items for PubMed ID: 18644979

  • 1. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
    Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, Guan XY.
    Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
    [Abstract] [Full Text] [Related]

  • 2. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE.
    PLoS One; 2011 Jul; 6(6):e20636. PubMed ID: 21695188
    [Abstract] [Full Text] [Related]

  • 3. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
    Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ.
    Cancer Res; 2011 Jun 01; 71(11):3991-4001. PubMed ID: 21498635
    [Abstract] [Full Text] [Related]

  • 4. Identification and characterization of tumorigenic liver cancer stem/progenitor cells.
    Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY.
    Gastroenterology; 2007 Jun 01; 132(7):2542-56. PubMed ID: 17570225
    [Abstract] [Full Text] [Related]

  • 5. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y, Pan G, Chen L, Ma S, Zeng T, Man Chan TH, Li L, Lian Q, Chow R, Cai X, Li Y, Li Y, Liu M, Li Y, Zhu Y, Wong N, Yuan YF, Pei D, Guan XY.
    Gastroenterology; 2015 Oct 01; 149(4):1068-81.e5. PubMed ID: 26099525
    [Abstract] [Full Text] [Related]

  • 6. Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.
    Chen X, Lingala S, Khoobyari S, Nolta J, Zern MA, Wu J.
    J Hepatol; 2011 Oct 01; 55(4):838-45. PubMed ID: 21334406
    [Abstract] [Full Text] [Related]

  • 7. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W.
    Int J Cancer; 2012 Jan 01; 130(1):29-39. PubMed ID: 21480217
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.
    Lingala S, Cui YY, Chen X, Ruebner BH, Qian XF, Zern MA, Wu J.
    Exp Mol Pathol; 2010 Aug 01; 89(1):27-35. PubMed ID: 20511115
    [Abstract] [Full Text] [Related]

  • 9. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J, Luo N, Luo Y, Peng Z, Zhang T, Li S.
    Int J Oncol; 2012 Mar 01; 40(3):747-56. PubMed ID: 22025269
    [Abstract] [Full Text] [Related]

  • 10. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.
    Cancer Genomics Proteomics; 2009 Mar 01; 6(1):19-29. PubMed ID: 19451087
    [Abstract] [Full Text] [Related]

  • 11. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L, Galetta D, Spaggiari L, Schmid RA, Karoubi G.
    Eur J Cardiothorac Surg; 2012 Jun 01; 41(6):e173-81. PubMed ID: 22529186
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.
    Zhang L, Li H, Ge C, Li M, Zhao FY, Hou HL, Zhu MX, Tian H, Zhang LX, Chen TY, Jiang GP, Xie HY, Cui Y, Yao M, Li JJ.
    Oncotarget; 2014 Nov 15; 5(21):10621-35. PubMed ID: 25301737
    [Abstract] [Full Text] [Related]

  • 13. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
    Ma S, Tang KH, Chan YP, Lee TK, Kwan PS, Castilho A, Ng I, Man K, Wong N, To KF, Zheng BJ, Lai PB, Lo CM, Chan KW, Guan XY.
    Cell Stem Cell; 2010 Dec 03; 7(6):694-707. PubMed ID: 21112564
    [Abstract] [Full Text] [Related]

  • 14. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD, Zhou L, Cheng L, Tian J, Jiang JJ, Maccallum J.
    Head Neck; 2009 Jan 03; 31(1):94-101. PubMed ID: 18853445
    [Abstract] [Full Text] [Related]

  • 15. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.
    Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J, Li J.
    Int J Cancer; 2010 May 01; 126(9):2067-78. PubMed ID: 19711346
    [Abstract] [Full Text] [Related]

  • 16. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity.
    Yin S, Li J, Hu C, Chen X, Yao M, Yan M, Jiang G, Ge C, Xie H, Wan D, Yang S, Zheng S, Gu J.
    Int J Cancer; 2007 Apr 01; 120(7):1444-50. PubMed ID: 17205516
    [Abstract] [Full Text] [Related]

  • 17. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F, Sasdelli F, Manini I, Gambarana C, Oliveri G, Miracco C, Sorrentino V.
    Cell Biol Int; 2012 Jan 01; 36(1):29-38. PubMed ID: 21916848
    [Abstract] [Full Text] [Related]

  • 18. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
    Tang KH, Ma S, Lee TK, Chan YP, Kwan PS, Tong CM, Ng IO, Man K, To KF, Lai PB, Lo CM, Guan XY, Chan KW.
    Hepatology; 2012 Mar 01; 55(3):807-20. PubMed ID: 21994122
    [Abstract] [Full Text] [Related]

  • 19. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
    Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee PW.
    Stem Cells; 2011 Jan 01; 29(1):32-45. PubMed ID: 21280157
    [Abstract] [Full Text] [Related]

  • 20. Biology and clinical implications of CD133(+) liver cancer stem cells.
    Ma S.
    Exp Cell Res; 2013 Jan 15; 319(2):126-32. PubMed ID: 22999864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.